AGP Picks
View all

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on July 6, 2026

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Elicio Therapeutics Announces Closing of $15 Million Registered Direct Offering
Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine
The Survivor We Didn't See Gives Voice To Healing, Resilience, And The Journey Beyond Trauma
WellSpan Health and Cancer Care Associates of York mark first day of integrated cancer care partnership
Dentistry Xposed: Protecting You, Your Smile, and Wallet Through Better Oral Health Awareness
Alberta Cancer Foundation invests $35-million to power cancer clinical trials for Albertans
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
[Latest] Generative AI in Healthcare Market Size to Ascend USD 21640 Mn by 2034 | Zion Market Research
Clareo Plastic Surgery Named Best Plastic Surgery Practice in Boston
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
MESA LABS DECLARES QUARTERLY DIVIDEND
Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million
Cannabix Technologies Announces Detection of Cocaine and Benzoylecgonine in Human Breath
Moleculin CEO, Walter Klemp, Highlights Positive Preliminary MIRACLE Trial Results in Virtual Investor "What This Means" Segment

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.